Immunocore Is A Biotechnology Company Based In Abingdonoxfordshireukfounded In 2000 As A Spin Off From Oxford Universitythe Company Specializes In Developing T Cell Receptortcrtherapies Aimed At Improving Patient Outcomes In Cancerinfectious Diseasesand Autoimmune Conditionsits Mission Is To Create Transformative Immunomodulating Medicines The Core Technology Of Immunocore Is The Immtax Platformwhich Includes Components Designed To Modulate The Immune Systemthis Platform Supports The Development Of Therapies Such As Immtac For Cancerimmtav For Infectious Diseases Like Hiv And Hbvand Immtaai For Autoimmune Conditionsthe Company S Lead Productkimmtraktebentafusp Is Approved For Treating Metastatic Uveal Melanoma And Is Being Tested For Other Melanoma Typesimmunocore Also Has Several Pipeline Candidates Targeting Various Cancers And Conditions Like Type 1 Diabetes Immunocore Collaborates With Industry Leadersacademiaand Charitable Organizationsincluding Genentechgskand The Bill & Melinda Gates Foundationto Enhance Its Immtax Platform And Improve Patient Care Through Innovative Therapies
No conferences found for this company.
| Company Name | Immunocore Ltd |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
